Incidence, Factors, and Prognostic Impact of Re-Exploration for Bleeding After Continuous-Flow Left Ventricular Assist Device Implantation ― A Japanese Single-Center Study ―
Open Access
- 23 October 2020
- journal article
- research article
- Published by Japanese Circulation Society in Circulation Journal
- Vol. 84 (11), 1949-1956
- https://doi.org/10.1253/circj.cj-20-0238
Abstract
Background:Continuous-flow left ventricular assist device (CF-LVAD) substantially improves survival in endstage heart failure patients. However, bleeding complications are common after CF-LVAD implantation and in some cases, re-exploration for bleeding is needed. We aimed to investigate the incidence, timing, and risk factors of bleeding requiring re-exploration after CF-LVAD implantation. Methods and Results:We retrospectively reviewed 162 consecutive patients (age 43±13 years, 71% men) who underwent CF-LVAD implantation (HeartMateII 119, Jarvik2000 15, HVAD 13, EVAHEART 10, DuraHeart 5) from January 2012 to June 2019. During follow-up [median 662 days, interquartile range (IQR) 364–1,116 days], 35 (21.6%) experienced re-exploration for bleeding. The median timing of re-exploration was 6 (IQR 1–10) days. In the multivariate logistic regression analysis, postoperative platelet count was an independent predictor for re-exploration for bleeding after CF-LVAD implantation (per 104/μL: odds ratio 0.83, 95% confidence interval 0.74–0.93, P=0.002). Patients who experienced re-exploration for bleeding had a significantly worse survival rate than patients who did not (at 4 years, 73.6% vs. 90.1%, P=0.039). Conclusions:Re-exploration for bleeding is prevalent after CF-LVAD implantation, especially in patients with low postoperative platelet counts. As bleeding requiring re-exploration is associated with poor prognosis, risk stratification using the postoperative platelet count may be beneficial for these patients.Keywords
This publication has 17 references indexed in Scilit:
- A Fully Magnetically Levitated Circulatory Pump for Advanced Heart FailureThe New England Journal of Medicine, 2017
- Risk factors, mortality, and timing of ischemic and hemorrhagic stroke with left ventricular assist devicesThe Journal of Heart and Lung Transplantation, 2016
- Active Clearance of Chest Tubes Reduces Re-Exploration for Bleeding After Ventricular Assist Device ImplantationASAIO Journal, 2016
- Results of the Destination Therapy Post-Food and Drug Administration Approval Study With a Continuous Flow Left Ventricular Assist DeviceJournal of the American College of Cardiology, 2014
- Readmissions After Implantation of Axial Flow Left Ventricular Assist DeviceJournal of the American College of Cardiology, 2013
- Re-exploration for bleeding or tamponade after cardiac operationInteractive CardioVascular and Thoracic Surgery, 2012
- Advanced Heart Failure Treated with Continuous-Flow Left Ventricular Assist DeviceThe New England Journal of Medicine, 2009
- Use of a Continuous-Flow Device in Patients Awaiting Heart TransplantationThe New England Journal of Medicine, 2007
- Chest Reexploration in the Intensive Care Unit After Cardiac Surgery: A Safe Alternative to Returning to the Operating TheaterThe Annals of Thoracic Surgery, 2006
- Long-Term Use of a Left Ventricular Assist Device for End-Stage Heart FailureThe New England Journal of Medicine, 2001